Mechanistically, SNX5 facilitates the internalization and inhibits the recycling of CD44 in ccRCC cells, thereby inhibiting EMT of ccRCC cells and exerting a tumor suppressor function. Here, CD44 is linked to nonpapillary renal cell carcinoma.